Evaluation of quality of life predictors in adolescents and young adults with cystic fibrosis

Tomaszek, Lucyna; Dębska, Grażyna; Cepuch, Grażyna; Kulpa, Marlena; Pawlik, Lidia; Broniatowska, Elżbieta

doi:10.1016/j.hrtlng.2018.08.003

Cited by 23 publications

(20 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Specifically in CF, both children and adults, report higher prevalence of chronic pain and perceive the disease as being painful [39]. Recently, chronic pain in CF patients has been reported as a correlate of poor sleep and reduced quality of life [40]. No study to date, had addressed these issues in PCD patients.…”

Section: Discussionmentioning

confidence: 99%

Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency

Cohen‐Cymberknoh

Atia

Gileles‐Hillel

et al. 2019

Respiratory Medicine

View full text Add to dashboard Cite

Background: Cystic fibrosis (CF) and primary ciliary dyskinesia (PCD) are characterized by impaired mucociliary clearance causing sinopulmonary infections and airway inflammation. However, they differ in many aspects including multisystemic involvement and disease severity. Aim: To compare sleep disorders and their correlation with quality of life (QOL) in three distinct patient populations: CF and pancreatic insufficiency (CF-PI), pancreatic sufficiency (CF-PS) and PCD. Methods: Patients completed age appropriate sleep quality questionnaires (SDSC, PSQI), quality of life questionnaires (PedQL, QOL-BE) and the Epworth sleepiness scale (ESS). Medical records were reviewed for clinical data. Results: Eighty patients, 33 CF-PI, 27 CF-PS, and 20 PCD; 40 females; 41 adults and 39 children completed the study. In adults, 66% slept less than 7 h per night, and sleep quality was reduced in 26.5%, 53% reported night wakings and 47% nocturnal snoring or coughing. In children 78% slept more than 8 h, SDSC scores were mostly in the normal range. A significant correlation was found between sleep quality and QOL in both age groups. Global sleep scores were correlated with hemoglobin levels. Despite differences in disease severity and QOL, there were no significant differences in sleep quality between the three groups. Conclusion: Sleep disorders are common and correlate with QOL in CF and PCD. Despite differences in disease characteristics and severity, there are no differences in terms of sleep disorders between CF-PI, CF-PS and PCD patients, suggesting that they may represent indirect outcomes of disease.

show abstract

Section: Discussionmentioning

confidence: 99%

Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency

Cohen‐Cymberknoh

Atia

Gileles‐Hillel

et al. 2019

Respiratory Medicine

View full text Add to dashboard Cite

show abstract

“…Psychological symptoms among children and adolescents with CF and their parent caregivers have a deleterious impact on health outcomes including worse adherence, decreased lung function, more frequent hospitalizations and health care outcomes ( Quittner et al., 2014 ). Additionally, experiencing anxiety and depressive symptoms has been associated with reduced quality of life in children and adolescents with CF ( Tomaszek et al., 2019 ). Given the functional impact of increased psychopathology in this population, addressing the mental health symptoms potentially faced by children and adolescents with CF is critical.…”

Section: Cystic Fibrosismentioning

confidence: 99%

Child Health and Illness

Wright

Power

Shivak

2022

Comprehensive Clinical Psychology

View full text Add to dashboard Cite

“…In 2018, Tomaszek et al [28] used the NRS tool for pain intensity evaluation in adolescents and young adults with CF. A score of 0 meant no pain, 1–3 was mild, 4–6 was moderate and 7–10 was given for severe pain.…”

Section: Pain In Cfmentioning

confidence: 99%

Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis

Trandafir

Leon

Frăsinariu

et al. 2019

JCM

View full text Add to dashboard Cite

Pain is a complex, multidimensional process that negatively affects physical and mental functioning, clinical outcomes, quality of life, and productivity for cystic fibrosis (CF) patients. CF is an inherited multi-system disease that requires a complete approach in order to evaluate, monitor and treat patients. The landscape in CF care has changed significantly, with currently more adult patients than children worldwide. Despite the great advances in supportive care and in our understanding regarding its pathophysiology, there are still numerous aspects of CF pain that are not fully explained. This review aims to provide a critical overview of CF pain research that focuses on pain assessment, prevalence, characteristics, clinical association and the impact of pain in children and adults, along with innovative nanotechnology perspectives for CF management. Specifically, the paper evaluates the pain symptoms associated with CF and examines the relationship between pain symptoms and disease severity. The particularities of gastrointestinal, abdominal, musculoskeletal, pulmonary and chest pain, as well as pain associated with medical procedures are investigated in patients with CF. Disease-related pain is common for patients with CF, suggesting that pain assessment should be a routine part of their clinical care. A summary of the use of nanotechnology in CF and CF-related pain is also given. Further research is clearly needed to better understand the sources of pain and how to improve patients’ quality of life.

show abstract

Evaluation of quality of life predictors in adolescents and young adults with cystic fibrosis

Cited by 23 publications

References 36 publications

Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency

Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency

Child Health and Illness

Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis

Contact Info

Product

Resources

About